LORAZEPAM

Lorazepam Adverse Events Reported to the FDA Over Time

How are Lorazepam adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lorazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lorazepam is flagged as the suspect drug causing the adverse event.

Most Common Lorazepam Adverse Events Reported to the FDA

What are the most common Lorazepam adverse events reported to the FDA?

Completed Suicide	804 (3.31%)
Suicide Attempt	573 (2.36%)
Somnolence	461 (1.9%)
Intentional Overdose	332 (1.37%)
Multiple Drug Overdose Intentional	318 (1.31%)
Cardiac Arrest	276 (1.14%)
Agitation	264 (1.09%)
Drug Interaction	263 (1.08%)
Tachycardia	261 (1.08%)
Respiratory Arrest	254 (1.05%)
Hypotension	241 (.99%)
	Show More
Anxiety	236 (.97%)
Fatigue	236 (.97%)
Coma	231 (.95%)
Overdose	231 (.95%)
Confusional State	221 (.91%)
Fall	215 (.89%)
Drug Ineffective	211 (.87%)
Vomiting	197 (.81%)
Cardio-respiratory Arrest	192 (.79%)
Poisoning	182 (.75%)
Delirium	173 (.71%)
Multiple Drug Overdose	169 (.7%)
Drug Toxicity	167 (.69%)
Depression	163 (.67%)
Drug Withdrawal Syndrome	163 (.67%)
Death	161 (.66%)
Loss Of Consciousness	161 (.66%)
Dizziness	150 (.62%)
Insomnia	143 (.59%)
Convulsion	137 (.56%)
Dyspnoea	133 (.55%)
Sedation	133 (.55%)
Depressed Level Of Consciousness	120 (.49%)
Disorientation	117 (.48%)
Tremor	117 (.48%)
Nausea	116 (.48%)
Headache	115 (.47%)
Bradycardia	112 (.46%)
Hallucination	112 (.46%)
Suicidal Ideation	112 (.46%)
Drug Dependence	110 (.45%)
Pyrexia	109 (.45%)
Drug Exposure During Pregnancy	105 (.43%)
Unresponsive To Stimuli	101 (.42%)
Neuroleptic Malignant Syndrome	100 (.41%)
Sopor	99 (.41%)
Gait Disturbance	97 (.4%)
Restlessness	96 (.4%)
Psychotic Disorder	93 (.38%)
Condition Aggravated	92 (.38%)
Hyperhidrosis	92 (.38%)
Asthenia	91 (.38%)
Self Injurious Behaviour	90 (.37%)
Diarrhoea	89 (.37%)
Medication Error	88 (.36%)
Feeling Abnormal	81 (.33%)
Respiratory Failure	81 (.33%)
Malaise	80 (.33%)
Drug Abuse	78 (.32%)
Serotonin Syndrome	78 (.32%)
Intentional Drug Misuse	75 (.31%)
Dehydration	73 (.3%)
Lethargy	72 (.3%)
Hypertension	71 (.29%)
Renal Failure Acute	71 (.29%)
Syncope	71 (.29%)
Dysarthria	69 (.28%)
Blood Glucose Increased	68 (.28%)
Mydriasis	68 (.28%)
Rhabdomyolysis	68 (.28%)
Electrocardiogram Qt Prolonged	67 (.28%)
Mental Status Changes	67 (.28%)
Sleep Disorder	67 (.28%)
Aggression	65 (.27%)
Bradyphrenia	65 (.27%)
Irritability	65 (.27%)
Constipation	64 (.26%)
Pneumonia Aspiration	64 (.26%)
Respiratory Depression	64 (.26%)
Amnesia	61 (.25%)
Blood Creatine Phosphokinase Increa...	61 (.25%)
Heart Rate Increased	60 (.25%)
Speech Disorder	60 (.25%)
Weight Decreased	60 (.25%)
Alcohol Use	58 (.24%)
Incorrect Dose Administered	58 (.24%)
Muscle Spasms	58 (.24%)
Abnormal Behaviour	57 (.23%)
Aspartate Aminotransferase Increase...	57 (.23%)
Paraesthesia	57 (.23%)
Pneumonia	57 (.23%)
Pain	56 (.23%)
Accidental Overdose	55 (.23%)
Disturbance In Attention	55 (.23%)
General Physical Health Deteriorati...	54 (.22%)
Visual Impairment	54 (.22%)
Dyskinesia	52 (.21%)
Blood Pressure Increased	51 (.21%)
Alanine Aminotransferase Increased	50 (.21%)
Myocardial Infarction	50 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Lorazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lorazepam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lorazepam

What are the most common Lorazepam adverse events reported to the FDA?

Neurological	2256 (9.3%)
Suicidal And Self-injurious Behavio...	1634 (6.73%)
Medication Errors	1410 (5.81%)
Cardiac Arrhythmias	1075 (4.43%)
Respiratory	919 (3.79%)
Therapeutic And Nontherapeutic Effe...	835 (3.44%)
Anxiety Disorders	674 (2.78%)
Gastrointestinal Signs	540 (2.23%)
Deliria	521 (2.15%)
Chemical Injury And Poisoning	518 (2.13%)
Movement Disorders	459 (1.89%)
	Show More
Psychiatric	456 (1.88%)
Injuries	425 (1.75%)
Cardiac And Vascular Investigations	385 (1.59%)
Sleep Disorders	367 (1.51%)
Disturbances In Thinking	363 (1.5%)
Decreased And Nonspecific Blood Pre...	326 (1.34%)
Epidermal And Dermal Conditions	319 (1.31%)
Muscle	317 (1.31%)
Infections - Pathogen Unspecified	285 (1.17%)
Neuromuscular	271 (1.12%)
Seizures	252 (1.04%)
Mental Impairment	245 (1.01%)
Depressed Mood Disorders	236 (.97%)
Hematology Investigations	231 (.95%)
Metabolic, Nutritional And Blood Ga...	230 (.95%)
Lifestyle Issues	218 (.9%)
Electrolyte And Fluid Balance Condi...	211 (.87%)
Hepatic And Hepatobiliary	210 (.87%)
Fatal Outcomes	197 (.81%)
Physical Examination Topics	192 (.79%)
Gastrointestinal Motility And Defec...	182 (.75%)
Hepatobiliary	182 (.75%)
Body Temperature Conditions	170 (.7%)
Musculoskeletal And Connective Tiss...	168 (.69%)
Ocular Neuromuscular	163 (.67%)
Water, Electrolyte And Mineral	159 (.66%)
Renal Disorders	157 (.65%)
Changes In Physical Activity	144 (.59%)
Mood Disorders	138 (.57%)
Urinary Tract Signs	134 (.55%)
Toxicology And Therapeutic Drug Mon...	133 (.55%)
Lower Respiratory Tract Disorders	132 (.54%)
Schizophrenia And Other Psychotic	132 (.54%)
Vision	132 (.54%)
Personality Disorders	127 (.52%)
Headaches	120 (.49%)
Skin Appendage Conditions	118 (.49%)
Cardiac Disorder Signs	108 (.45%)
Enzyme	108 (.45%)
Appetite And General Nutritional	95 (.39%)
Renal And Urinary Tract Investigati...	94 (.39%)
White Blood Cell	87 (.36%)
Coronary Artery	81 (.33%)
Vascular Hypertensive	80 (.33%)
Acid-base	79 (.33%)
Psychiatric And Behavioural Symptom...	79 (.33%)
Inner Ear And Viiith Cranial Nerve	77 (.32%)
Oral Soft Tissue Conditions	75 (.31%)
Vascular	72 (.3%)
Encephalopathies	71 (.29%)
Central Nervous System Vascular	68 (.28%)
Joint	66 (.27%)
Cardiac And Vascular Disorders Cong...	64 (.26%)
Bone And Joint Injuries	63 (.26%)
Platelet	59 (.24%)
Salivary Gland Conditions	59 (.24%)
Product Quality Issues	58 (.24%)
Therapeutic Procedures And Supporti...	55 (.23%)
Bacterial Infectious	54 (.22%)
Anemias Nonhemolytic And Marrow Dep...	51 (.21%)
Gastrointestinal Conditions	50 (.21%)
Hematological And Lymphoid Tissue T...	50 (.21%)
Legal Issues	49 (.2%)
Pulmonary Vascular	49 (.2%)
Manic And Bipolar Mood Disorders	48 (.2%)
Sleep Disturbances	46 (.19%)
Eye	45 (.19%)
Heart Failures	45 (.19%)
Obstetric And Gynecological Therape...	44 (.18%)
Allergic Conditions	42 (.17%)
Protein And Chemistry Analyses	40 (.16%)
Upper Respiratory Tract Disorders	40 (.16%)
Neurological, Special Senses And Ps...	39 (.16%)
Procedural And Device Related Injur...	39 (.16%)
Dissociative	38 (.16%)
Glucose Metabolism Disorders	38 (.16%)
Abortions And Stillbirth	37 (.15%)
Neonatal And Perinatal Conditions	37 (.15%)
Communication Disorders	36 (.15%)
Lipid Analyses	36 (.15%)
Viral Infectious	36 (.15%)
Cranial Nerve Disorders	35 (.14%)
Tongue Conditions	35 (.14%)
Endocrine Investigations	32 (.13%)
Gastrointestinal Stenosis And Obstr...	32 (.13%)
Myocardial	32 (.13%)
Ocular Infections, Irritations And ...	30 (.12%)
Skin Vascular Abnormalities	29 (.12%)
Pregnancy, Labour, Delivery And Pos...	28 (.12%)
Gastrointestinal Inflammatory Condi...	27 (.11%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lorazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lorazepam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.